Literature DB >> 16362550

Pyridostigmine in the treatment of orthostatic hypotension.

Jean-Michel Senard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16362550     DOI： 10.1007/s10286-005-0321-4

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  17 in total

1.  Muscarinic receptor-mediated pyridostigmine-induced neuronal apoptosis.

Authors:  L Li; P G Gunasekar; J L Borowitz; G E Isom
Journal:  Neurotoxicology       Date:  2000-08       Impact factor: 4.294

2.  Symptoms and medical conditions in Australian veterans of the 1991 Gulf War: relation to immunisations and other Gulf War exposures.

Authors:  H L Kelsall; M R Sim; A B Forbes; D C Glass; D P McKenzie; J F Ikin; M J Abramson; L Blizzard; P Ittak
Journal:  Occup Environ Med       Date:  2004-12       Impact factor: 4.402

3.  Reversal of antihypertensive agent-induced postural hypotension with physostigmine.

Authors:  K H Park; J P Long; J G Cannon
Journal:  Arch Int Pharmacodyn Ther       Date:  1991 May-Jun

4.  Spurious hyperchloremia and hyperbicarbonatemia in a patient receiving pyridostigmine bromide therapy for myasthenia gravis.

Authors:  I Wacks; J R Oster; G O Pérez; D H Kett
Journal:  Am J Kidney Dis       Date:  1990-07       Impact factor: 8.860

5.  Parkinsonism induced by pyridostigmine.

Authors:  Y Iwasaki; N Wakata; M Kinoshita
Journal:  Acta Neurol Scand       Date:  1988-09       Impact factor: 3.209

6.  Peripheral cholinergic pathway modulates hyperthermia induced by stress in rats exposed to open-field stress.

Authors:  Pamela Johnson Rowsey; Yong-Lu Yang; Christopher J Gordon
Journal:  J Appl Physiol (1985)       Date:  2002-02

7.  Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects.

Authors:  A C Nóbrega; A F dos Reis; R S Moraes; B G Bastos; E L Ferlin; J P Ribeiro
Journal:  Clin Auton Res       Date:  2001-02       Impact factor: 4.435

8.  [Paradoxal lowering of parasympathetic indices in myasthenic patients].

Authors:  M P Douchet; E Quiring; F Bronner; R Vi-Fane; M Messier; M Chauvin; J M Warter
Journal:  Arch Mal Coeur Vaiss       Date:  1999-06

9.  Cholinergic stimulation with pyridostigmine reduces the QTc interval in coronary artery disease.

Authors:  R R T Castro; G Porphirio; S M Serra; A C L Nóbrega
Journal:  Braz J Med Biol Res       Date:  2002-06       Impact factor: 2.590

10.  Pyridostigmine bromide (PYR) alters immune function in B6C3F1 mice.

Authors:  M M Peden-Adams; A C Dudley; J G EuDaly; C T Allen; G S Gilkeson; D E Keil
Journal:  Immunopharmacol Immunotoxicol       Date:  2004-02       Impact factor: 2.730
View more
  2 in total

1.  Acetylcholinesterase inhibition and orthostatic hypotension.

Authors:  Vincenzo Provitera; Maria Nolano; Angela Pagano
Journal:  Clin Auton Res       Date:  2006-04       Impact factor: 4.435

Review 2.  The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Authors:  Christopher H Gibbons; Peter Schmidt; Italo Biaggioni; Camille Frazier-Mills; Roy Freeman; Stuart Isaacson; Beverly Karabin; Louis Kuritzky; Mark Lew; Phillip Low; Ali Mehdirad; Satish R Raj; Steven Vernino; Horacio Kaufmann
Journal:  J Neurol       Date:  2017-01-03       Impact factor: 4.849
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.